Topic

Articles

A glimpse inside the latest turn in Liz Barrett’s influential journey as an oncology executive—this time leaving the confines of big pharma to tackle the innovation void in treating urologic cancers.


Stepping Out in Oncology

Filippo Petti is CEO of Celyad Oncology tells Pharm Exec how the pandemic has affected his role as a US-based CEO to a Belgian company.

Leading On Two Continents through COVID-19: Filippo Petti, Celyad Oncology

's Online and European Editor. He can be reached at jupton@mjhlifesciences.com

EXUMA Biotech's Dr. Greg Frost talks about his work making CAR-T cell therapy readily accessible and affordable.

Expanding Access to CAR-T: Dr. Greg Frost

Patrick Soon-Shiong, the billionaire biotech entrepreneur and owner of NantWorks, a network of health startups, discusses his companies’ COVID-19 vaccine candidate and its “fighting chance” to outsmart the virus’s hidden tricks through merging supercomputing and modernized DNA delivery.

Tackling a ‘Genius Virus’

Former physician and clinical researcher Antony Loebel, now president and CEO of Sunovion Pharmaceuticals, discusses his career-long mission to advance novel treatments for patients suffering from serious and underserved CNS disorders.

Central Focus: Targeting Unmet Need in CNS

Pharm Exec speaks with Arndt Rolfs, CEO and founder of CENTOGENE, who discusses his company’s rise from a small genetic diagnostics startup to a global organization focused on advancing the understanding of the pathophysiology of rare hereditary diseases.

Rare Insights: Arndt Rolfs, CENTOGENE

Pharm Exec presents the diverse stories of 11 rising biopharma managers.

Pharm Exec's Emerging Pharma Leaders 2020

Elaine Quilici is Pharmaceutical Executive's Senior Editor. Email her at equilici@mmh.com

For Sandra Horning, this year's Healthcare Businesswomen’s Association Woman of the Year, harnessing the patient experience has been the driving force in a career-spanning-and service-focused-mission to fight disease and accelerate the delivery of new medicines.

HBA's Woman of the Year 2020: A Motivated Mission

AstraZeneca’s Habib Bennaceur talks about the key transitions in his career-from local to global-and his current role in positioning AZ’s Farxiga as a drug with the potential to impact the lives of both patients with and without type 2 diabetes.


Habib Bennaceur: Following the Science

Banks Bourne of Tanner Pharma Group talks about the organization's role in delivering access initiatives for products not commercially available in many parts of the world.

Executive Profiles